Shandong Bailong Stock Hits Day Low of CNY 21.50 Amid Price Pressure

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. experienced a significant decline today, with the stock dropping by 9.24% as it reached an intraday low of CNY 21.50. This performance stands in contrast to the China Shanghai Composite, which fell by 3.05% on the same day. Over the past week, the stock has decreased by 6.6%, and its monthly performance shows a decline of 14.82%. Despite these short-term challenges, Shandong Bailong has reported positive results over the last four consecutive quarters, with net sales for the first nine months reaching CNY 965.1 million, reflecting a growth rate of 17.89%. The company has also achieved a notable operating cash flow of CNY 367.92 million, and its return on equity stands at 19.58%. In terms of market position, Shandong Bailong maintains a mid-cap status with a market capitalization of CNY 10,089 million. The stock's price-to-earnings ratio is 25.00, and it has a price-to-book ratio of 4.85. While the stock has faced recent volatility, it has outperformed the China Shanghai Composite over various time frames, including the past year, where it generated a return of 73.77%.